ANRO – alto neuroscience, inc. (US:NASDAQ)
Stock Stats
News
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression [Yahoo! Finance]
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology [Yahoo! Finance]
Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Chardan Capital from $15.00 to $30.00. They now have a "buy" rating on the stock.
Form 4 Alto Neuroscience, Inc. For: Jan 02 Filed by: York Gwill
Form 4 Alto Neuroscience, Inc. For: Jan 02 Filed by: Cox Christopher Nixon
Form 4 Alto Neuroscience, Inc. For: Jan 02 Filed by: Sanchez Ramiro
Form 4 Alto Neuroscience, Inc. For: Jan 02 Filed by: Manji Husseini
Form EFFECT Alto Neuroscience, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.